The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.00
Bid: 87.20
Ask: 87.90
Change: -1.80 (-2.03%)
Spread: 0.70 (0.803%)
Open: 87.90
High: 88.40
Low: 87.00
Prev. Close: 88.80
CLI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of a £154 million long-term, green loan

30 Sep 2020 07:00

RNS Number : 4974A
CLS Holdings PLC
30 September 2020
 

 

Release date: 30 September 2020

Embargoed until: 07:00 am

 

 

 

CLS Holdings plc ("CLS")

announces the completion of a £154 million long-term, green loan with Aviva Investors

 

CLS announces that it has completed a £154 million loan with Aviva Investors which is secured on a portfolio of 12 UK properties. This loan replaces three existing loans of £67 million, which were due to expire in 2020 and 2021, as well as gearing unencumbered properties and will result in net additional cash to CLS of £86 million, after costs. Subject to certain conditions, CLS will be able to remove or substitute properties as security for the loan.

 

Over 60% of the properties by value are offices including 166 College Road, Harrow and Twenty Kingston Road, Staines, which were acquired earlier this year, as well as the office, hotel and student accommodation at our mixed-use Spring Mews property in Vauxhall. The offices have a WAULT of 5.2 years.

 

The £154 million loan, which has a loan to value of 55%, is in two tranches split equally between 10-year and 12-year tranches. The average interest rate is 2.62% fixed.

 

The loan has been independently assured as a "green loan" in line with LMA sustainability principles with up to a 10-basis point margin reduction dependent on the delivery of specific sustainability targets. As noted, cash and gross debt will increase by £86 million with net debt and gearing remaining unchanged at c.35%. Weighted average debt maturity will increase from 3.1 years as at 30 June 2020 to 4.5 years on a pro forma basis. The additional funds will increase CLS' cash reserves and allow for the evaluation of further acquisition opportunities.

 

Andrew Kirkman, Chief Financial Officer of CLS, commented:

"We are pleased to have secured this £154m loan with such a well-established real estate funder as Aviva Investors. This loan increases our weighted average loan maturity by nearly 50% to 4.5 years. Moreover, we are delighted that the loan recognises our sustainability progress and incentivises our future target delivery while aligning our sustainability commitment to that of Aviva Investors."

 

Gregor Bamert, Head of Real Estate Debt at Aviva Investors, commented:

"We are delighted to support CLS and the strong emphasis it places on the provision of a sustainable portfolio. This transaction builds on our experience of incentivising borrowers to bring the green credentials of their portfolios into sharper focus and we are pleased to have received independent assurance that the facility is aligned with LMA sustainability linked loan principals. The wide range of investment capital used within the facility further underlines our ability to tailor debt solutions for borrowers whilst delivering strong opportunities for our investor clients."

 

-ends-

 

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Limited

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Elm Square Advisers Limited

Jonathan Gray

+44 (0)20 7823 3695

 

Smithfield Consultants (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2546

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBLGDCIXDDGGC
Date   Source Headline
23rd Oct 20207:00 amRNSDisposal
8th Oct 20205:49 pmRNSDirector/PDMR Shareholding
8th Oct 20207:00 amRNSCLS Holdings Trading Update
30th Sep 20207:00 amRNSCompletion of a £154 million long-term, green loan
14th Sep 20207:00 amRNSAcquisition
10th Sep 20208:39 amRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSEPRA Index Inclusion
13th Aug 20201:31 pmRNSDirector/PDMR Shareholding
12th Aug 20203:18 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNSHalf-year Report
5th Aug 202010:00 amRNSNotice of Results
24th Jul 20207:00 amRNSDisposal
14th Jul 202011:20 amRNSDirector/PDMR Shareholding
8th Jul 20207:00 amRNSTrading Statement
15th Jun 202012:57 pmRNSDirector/PDMR Shareholding
1st Jun 20207:00 amRNSAcquisition
13th May 20206:02 pmRNSDirector/PDMR Shareholding
13th May 20206:00 pmRNSDirector/PDMR Shareholding
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.